SEC Form 4 · accession 0001209191-18-038098
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — SVP, Finance and CFO
Period of report
Jun 13, 2018
Accepted (ET)
Jun 15, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 13, 2018 | S | 2,319 | $57.70 | D | 224,704 | D | |
| Common Stock | Jun 14, 2018 | M | 7,750 | $25.40 | A | 232,454 | D | |
| Common StockF1 | Jun 14, 2018 | S | 7,750 | $60.00 | D | 224,704 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $25.40 | Jun 14, 2018 | M | 7,750 | D | — | Mar 8, 2027 | Common Stock | 7,750 | 50,250 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.